Objectives Integrated positron emission tomography/computed tomography (PET/CT) using Rubidium-82 is increasingly being utilized for myocardial perfusion imaging. Rb-82 is a potassium analogue like ...

Right: Kaplan–Meier curves show that high uptake and presence of metastatic disease on PET are associated with earlier biochemical recurrence. Credit Image created by F Moradi, Stanford ...

FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing ...

M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.

An incidental focal esophageal uptake was noted on PET/CT, without associated mass. Subsequent endoscopy revealed Barrett's esophagus. The second patient, a 63- year-old Caucasian man, underwent a PET ...

The evidence does not support clinical impact of radioligand choice PSMA PET is one class of imaging, however, specific pitfalls exist, for example, ureter/bladder uptake for PSMA-11/DCFPyL and bone ...

Results Intense PSMA expression by the extensive bone and lymph node metastases (n=4), lung metastases (n=1 ... by baseline Ga-68 PSMA-HBED-CC PET/CT. All lesions detected by PET/CT exhibited high ...

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

Unable to lie flat, still or tolerate a PET scan. Prior history of any other malignancy within the last 2 years, other than skin basal cell or cutaneous superficial squamous cell carcinoma that has ...

Positron Emission Tomography-Computed Tomography (PET-CT) provides structural and functional information about the lung. A study of 25 IPF patients reported increased 18[F]-FDG uptake in areas of ...

Data from 611 FDG PET/CT scans of patients with lung cancer, melanoma, lymphoma, head and neck cancer, and breast cancer, as well as 408 PSMA PET/CT ... tumor burden and uptake across all cancer ...

More information: Motohiko Yamazaki et al, 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors, Academic Radiology (2024).